Merck has announced a strategic technology collaboration with Transcenta, a global biotherapeutics company headquartered...
China's Porton Biologics is committed to building an end-to-end gene and cell therapy CDMO service platform. The Op...
Thermo Fisher Scientific and Symphogen, an affiliate of and the antibody center of excellence within the international p...
Merck has recently announced a collaboration with Mammoth Biosciences Inc. of South San Francisco, California, USA, for ...
Avidity Science, a leader in water purification and delivery, control and monitoring and service solutions for the ...
TUV Rheinland, a global leader in independent technical services on 23 Oct 2020 announced the opening of its Biomaterial...
Samsung Biologics has entered into a partnership agreement with BioEleven to develop and manufacture BN-101A, a third-ge...
Singapore's Rockwell Automation on 15 Oct 2020 released the PlantPAx® 5.0 distributed control system (DCS). Thi...
Malaysia's Solution Biologics Sdn Bhd (SOLBIO), a subsidiary of Solution Group Bhd, has inked a deal with China based Ca...
Japan's Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development a...
Samsung Biologics has entered into a service agreement with Panolos Bioscience to develop PB101, an Fc-fusion protein in...
South Korea based PharmAbcine, a biotech company focusing on the development of antibody therapeutics, has announced&nbs...
Viva Biotech (Shanghai) Co., Ltd. has entered into the Share Purchase Agreement pursuant to which Viva Biotech agreed to...
South Korean firm Samsung Biologics has announced a plan to expand its Drug Product (DP) capability in line with increas...
HOYA Corporation and Hitachi, Ltd. on 6 July 2020 announced a five-year contract regarding Endoscopic Ultrasound Systems...
South Korea based PharmAbcine, a biotech company focusing on the development of antibody therapeutics, announced that it...
UK headquartered GlaxoSmithKline plc and South Korea based Samsung Biologics have entered into a partnership to provide ...
AstraZeneca is advancing its ongoing response to address the unprecedented challenges of COVID-19, collaborating with a ...
